8Q1C
Substrate-free D10N,P146A variant of beta-phosphoglucomutase from Lactococcus lactis
8Q1C の概要
エントリーDOI | 10.2210/pdb8q1c/pdb |
関連するPDBエントリー | 2WHE 6H93 6YDK |
分子名称 | Beta-phosphoglucomutase, MAGNESIUM ION, 1,2-ETHANEDIOL, ... (6 entities in total) |
機能のキーワード | mutase, isomerase |
由来する生物種 | Lactococcus lactis subsp. lactis Il1403 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 48970.05 |
構造登録者 | Cruz-Navarrete, F.A.,Baxter, N.J.,Flinders, A.J.,Buzoianu, A.,Cliff, M.J.,Baker, P.J.,Waltho, J.P. (登録日: 2023-07-31, 公開日: 2024-08-07) |
主引用文献 | Cruz-Navarrete, F.A.,Baxter, N.J.,Flinders, A.J.,Buzoianu, A.,Cliff, M.J.,Baker, P.J.,Waltho, J.P. Peri active site catalysis of proline isomerisation is the molecular basis of allomorphy in beta-phosphoglucomutase. Commun Biol, 7:909-909, 2024 Cited by PubMed Abstract: Metabolic regulation occurs through precise control of enzyme activity. Allomorphy is a post-translational fine control mechanism where the catalytic rate is governed by a conformational switch that shifts the enzyme population between forms with different activities. β-Phosphoglucomutase (βPGM) uses allomorphy in the catalysis of isomerisation of β-glucose 1-phosphate to glucose 6-phosphate via β-glucose 1,6-bisphosphate. Herein, we describe structural and biophysical approaches to reveal its allomorphic regulatory mechanism. Binding of the full allomorphic activator β-glucose 1,6-bisphosphate stimulates enzyme closure, progressing through NAC I and NAC III conformers. Prior to phosphoryl transfer, loops positioned on the cap and core domains are brought into close proximity, modulating the environment of a key proline residue. Hence accelerated isomerisation, likely via a twisted anti/C4-endo transition state, leads to the rapid predominance of active cis-P βPGM. In contrast, binding of the partial allomorphic activator fructose 1,6-bisphosphate arrests βPGM at a NAC I conformation and phosphoryl transfer to both cis-P βPGM and trans-P βPGM occurs slowly. Thus, allomorphy allows a rapid response to changes in food supply while not otherwise impacting substantially on levels of important metabolites. PubMed: 39068257DOI: 10.1038/s42003-024-06577-9 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.679 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
